Ovoca is pleased to announce that IVIX has signed an agreement with Biopharma Excellence GmbH (Germany), an experienced biopharmaceutical drug development consultancy firm, to provide regulatory affairs services.
Ovoca is pleased to announce that on 25th of September 2018 the notary public notified the Company that its subsidiary, Silver Star Ltd., has been formally registered on the Russian Unified State Register of Legal Entities as the owner of ...
On 27th of July 2018, Ovoca Gold Plc held Annual General Meeting and Extraordinary General Meeting in Radisson Blu St Helen hotel in Dublin, as it was announced on 4th of July 2018.
|September 16, 2019||Interim Results|
|September 12, 2019||Filing of Marketing Authorisation Application with Russian Ministry of Health for BP-101|
|August 28, 2019||Directorate Change|
|June 28, 2019||Annual Report 2018|
|May 25, 2018||Annual Report 2017|
|June 30, 2017||Annual Report 2016|
|March 29, 2019||Ovoca Bio plc | Libicore Presentation|
|July 27, 2018||Ovoca Bio plc | Libicore Presentation|